Ginsenoside Rb1 ameliorates hippocampal neuroinflammation in rats after intracerebral hemorrhage by inactivating the TLR4/NF-kB pathway
Ginsenoside Rb1 has promising future for clinical ICH treatment, which exerts therapeutic effect on ICH by ameliorating hippocampal neuroinflammation via inactivating the TLR4/NF-kB pathway.
Authors
- Xiyun Fei
- Yan Zhong (ORCID: https://orcid.org/0000-0003-2412-043X)
- Jixin Duan
- Ling Han
- Yuying Wang (ORCID: https://orcid.org/0000-0001-5946-2320)
- Xi Liu (ORCID: https://orcid.org/0000-0002-1433-2917)
- Zhijun Zhong (ORCID: https://orcid.org/0009-0003-1071-7160)
- Li Xing (ORCID: https://orcid.org/0000-0002-4186-7909)
- Jilin Zhou
- Min Peng
Institutions
- Hunan University of Traditional Chinese Medicine (CN)
- Hunan Mawangdui Hospital (CN)
- Hunan Academy of Traditional Chinese Medicine (CN)
- Hunan Provincial People's Hospital (CN)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1093/jpp/rgae145
- Citations
- 5
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- article
- Field-Weighted Citation Impact
- 1.85